• Fresenius Medical Care AG FMS.N reported quarterly adjusted earnings of 41 cents​​ per share for the quarter ended March 31, identical to the same quarter last year. The mean expectation of two analysts for the quarter was for earnings of 38 cents per share. Wall Street expected results to range from 28 cents to 48 cents per share.

• Revenue rose 3.3% to €4.88 billion from a year ago; analysts expected €4.78 billion.

• Fresenius Medical Care AG's reported EPS for the quarter was 26 cents​.

• Fresenius Medical Care AG shares had risen by 2.9% this quarter and gained 13.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 16.5% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

• Wall Street's median 12-month price target for Fresenius Medical Care AG is $25.00

This summary was machine generated from LSEG data May 6 at 07:14 a.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)